Source - RNS
RNS Number : 0316K
Sportech PLC
11 December 2018
 

For immediate release

11 December 2018

 

Sportech PLC

 

('Sportech' or the 'Company')

 

Appointment of Independent Non-Executive Director

 

Sportech PLC (LSE: SPO), the international betting technology business, is pleased to announce the appointment of Christian ('Chris') Rigg as an Independent Non-Executive Director of the Company with effect from 1 January 2019.

 

Chris has considerable business and boardroom experience, latterly in executive roles at public and private companies.  He has previously held both non-executive and executive directorships at quoted companies including Clinigen Group PLC ('Clinigen') and Quantum Pharma PLC ('Quantum').

 

Chris qualified as a chartered accountant at PwC and then moved to corporate finance at Deloitte for eight years.  In 2009, he joined energy efficiency company Eaga PLC ('Eaga'), first as Group Corporate Finance Director, and subsequently as Divisional Managing Director of the solar division.  After Eaga's acquisition by Carillion PLC in 2011, Chris joined Barclays PLC to head its North East corporate banking division in the UK.  Two years later, Chris became Chief Executive Officer of Northern Recruitment Group Limited ('NRG'), a national recruitment agency, where he worked at until joining Quantum in November 2015.  During his time at Quantum, Chris held a number senior positions including Group Strategic Director, Chief Financial Officer and Chief Executive Officer.  Under his stewardship at Quantum, Chris implemented a new strategy which helped simplify and grow the business and led to the acquisition of Quantum by Clinigen for an enterprise value of £160 million.

 

Richard McGuire, Executive Chairman of Sportech, said: "We are delighted to welcome Chris to the Board.  His extensive experience at a senior level within public and private companies will undoubtedly be of great value to Sportech."

 

As required to be notified under Section 9.6.13 (1) to (6) of the Listing Rules, Mr Rigg, when Chief Executive Officer of Quantum, placed NuPharm Group Limited into administration as part of a successful turnaround strategy to simplify the wider business.

 

There are no other disclosures required under Section 9.6.13 (1) to (6) of the Listing Rules.

 

The Board continues to assess further independent non-executive candidates and anticipates making a further appointment in early 2019.

 

- Ends -

 

Contacts:

 

Sportech PLC

Tel: +44 (0) 20 7268 2400

Richard McGuire, Executive Chairman

 

Giles Vardey, Non-Executive Director

 

 

 

Peel Hunt

Tel: +44 (0) 20 7418 8900

(Corporate Broker to Sportech)

Dan Webster / George Sellar / Guy Pengelley

 

 

 

 

Buchanan

Tel: +44 (0) 20 7466 5000

(Financial PR adviser to Sportech)

Henry Harrison-Topham / Mark Court / Jamie Hooper

[email protected]

 

Notes to Editors:

 

About Sportech

Sportech PLC, the international betting technology business, provides and operates betting technology solutions for some of the world's best-known gaming companies, sports teams, and horse and greyhound racetracks, as well as owning and operating its own gaming venues in Connecticut under exclusive licences.

 

The Group focuses on highly regulated markets worldwide. It has more than 27,000 betting terminals deployed to over 400 clients in 37 countries.  Its global systems process nearly US$12 billion in betting handle annually.  In the US, it operates under 35 licences across 37 states.  The Group has invested over US$60 million in the last five years in the successful expansion of its US gaming Venues and in developing its technology services, resulting in its proprietary Quantum™ System being the most widely deployed pari-mutuel betting system globally.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BOAUROBRWRAUAAA